ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2017. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,075 | -29.5% | 72,525 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $100,810 | +51863.9% | 72,525 | -40.5% | 0.00% | -66.7% |
| Q1 2023 | $194 | -63.3% | 121,981 | +43.6% | 0.00% | -70.0% |
| Q4 2022 | $529 | -99.9% | 84,949 | +18.9% | 0.01% | 0.0% |
| Q3 2022 | $479,000 | +64.0% | 71,444 | +55.7% | 0.01% | +25.0% |
| Q2 2022 | $292,000 | -13.4% | 45,897 | -36.7% | 0.01% | 0.0% |
| Q1 2022 | $337,000 | -6.9% | 72,524 | +0.2% | 0.01% | +33.3% |
| Q4 2021 | $362,000 | -57.4% | 72,356 | +2.5% | 0.01% | -57.1% |
| Q3 2021 | $850,000 | +37.1% | 70,571 | +140.6% | 0.01% | +16.7% |
| Q2 2021 | $620,000 | -24.7% | 29,334 | 0.0% | 0.01% | -29.4% |
| Q1 2021 | $823,000 | -18.4% | 29,334 | -24.4% | 0.02% | -39.3% |
| Q4 2020 | $1,008,000 | +189.7% | 38,780 | +314.4% | 0.03% | +86.7% |
| Q3 2020 | $348,000 | -24.3% | 9,359 | -5.4% | 0.02% | +15.4% |
| Q2 2019 | $460,000 | +123.3% | 9,890 | +92.3% | 0.01% | +44.4% |
| Q1 2019 | $206,000 | -58.0% | 5,143 | -51.8% | 0.01% | -10.0% |
| Q4 2018 | $491,000 | -77.2% | 10,674 | -75.2% | 0.01% | -81.8% |
| Q3 2017 | $2,153,000 | +295.0% | 42,954 | +85.9% | 0.06% | +205.6% |
| Q3 2015 | $545,000 | -0.4% | 23,100 | +291.3% | 0.02% | 0.0% |
| Q1 2015 | $547,000 | +189.4% | 5,903 | -41.0% | 0.02% | +125.0% |
| Q3 2013 | $189,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |